The second good indication for colorectal stenting is the palliative treatment of patients with malignant colorectal obstruction. So patients with stage four disease and obstruction, and you have to offer something to improve the symptoms and offer better quality of life. In the systematic review and meta-analysis, the authors compared through the results of four randomized control trials who compared stenting versus surgery to palliate stage four disease, colorectal cancer. And these four randomized control trials comprised of more than 100 patients. And in terms of mortality, mean survival, length of stay in the ICU and other complications, there was absolutely no difference between colorectal stenting and surgery. And the authors also observed that hospital stay was shorter and the risk of permanent stoma was lower in the SEMS group. And more important, when we talk about patients with stage four disease, quality of life is our main objective. And in this study, the authors evaluated the impact of the disease on the quality of life of stented patients versus operated patients. And they observed the impact of the disease on quality of life was lower in the stenting group. As you may see here, the red bars show better quality of life in the stent group. And here, negative impact on quality of life, red bars, stenting group. But you see here, the surgical group, always blue bars showing worst quality of life in all items. So stenting offers better quality of life. This is the bottom line. Stenting offers better quality of life compared to surgery in patients who need spalliation for obstruction caused by colorectal cancer. So once again, this is a very good indication. Patients in this situation are good candidates for colorectal stenting. Thank you.

colorectal stenting

palliative treatment

malignant colorectal obstruction

quality of life

colorectal cancer